Mithra Ghalibafian

Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelines

T. Girinsky, Richard van der Maazen, Lena Specht et al. · Radiotherapy and Oncology · 2006 · 374 citations

Medicine, Oncology, Radiation Oncology +9

Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin’s disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?

T. Girinsky, C. Pichenot, A. Beaudré et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 118 citations

Medicine, Oncology, Radiation Oncology +17

Dosimetric Benefits of Intensity-Modulated Radiotherapy Combined With the Deep-Inspiration Breath-Hold Technique in Patients With Mediastinal Hodgkin's Lymphoma

A. Paumier, Mithra Ghalibafian, Jennifer Gilmore et al. · International Journal of Radiation Oncology*Biology*Physics · 2011 · 116 citations

Medicine, Oncology, Radiation Oncology +14

The conundrum of hodgkin lymphoma nodes: To be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines

T. Girinsky, Lena Specht, Mithra Ghalibafian et al. · Radiotherapy and Oncology · 2008 · 112 citations

Medicine, Oncology, Radiation Oncology +15

Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance

Carol Durno, Ayse B. Ercan, Vanessa Bianchi et al. · Journal of Clinical Oncology · 2021 · 101 citations · Full text

Medicine, Oncology, Dna Repair +16